Global Regenerative Medicine Market Growth (Status and Outlook) 2019-2024

Published On: Mar 2019

Format: PDF

Publisher: LP infomation

Pages: 151

Report ID: 236816

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
The classification of Regenerative Medicine includes Cell Therapy and Tissue Engineering, Biomaterial and Others, and the proportion of Tissue Engineering is about 41% in 2017, and the proportion is in increasing trend from 2013 to 2017.

According to this study, over the next five years the Regenerative Medicine market will register a 19.3% CAGR in terms of revenue, the global market size will reach US$ 47800 million by 2024, from US$ 19800 million in 2019. In particular, this report presents the global revenue market share of key companies in Regenerative Medicine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Regenerative Medicine market by product type, application, key companies and key regions.

This study considers the Regenerative Medicine value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Cell Therapy
Tissue Engineering
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Dermatology
Cardiovascular
CNS
Orthopedic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
J & J (DePuy Synthes)
Medtronic
ZimmerBiomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Regenerative Medicine market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Regenerative Medicine market by identifying its various subsegments.
Focuses on the key global Regenerative Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Regenerative Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Regenerative Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Regenerative Medicine Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Regenerative Medicine Market Size 2014-2024
2.1.2 Regenerative Medicine Market Size CAGR by Region
2.2 Regenerative Medicine Segment by Type
2.2.1 Cell Therapy
2.2.2 Tissue Engineering
2.2.3 Biomaterial
2.2.4 Others
2.3 Regenerative Medicine Market Size by Type
2.3.1 Global Regenerative Medicine Market Size Market Share by Type (2014-2019)
2.3.2 Global Regenerative Medicine Market Size Growth Rate by Type (2014-2019)
2.4 Regenerative Medicine Segment by Application
2.4.1 Dermatology
2.4.2 Cardiovascular
2.4.3 CNS
2.4.4 Orthopedic
2.4.5 Others
2.5 Regenerative Medicine Market Size by Application
2.5.1 Global Regenerative Medicine Market Size Market Share by Application (2014-2019)
2.5.2 Global Regenerative Medicine Market Size Growth Rate by Application (2014-2019)

3 Global Regenerative Medicine by Players
3.1 Global Regenerative Medicine Market Size Market Share by Players
3.1.1 Global Regenerative Medicine Market Size by Players (2017-2019)
3.1.2 Global Regenerative Medicine Market Size Market Share by Players (2017-2019)
3.2 Global Regenerative Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Regenerative Medicine by Regions
4.1 Regenerative Medicine Market Size by Regions
4.2 Americas Regenerative Medicine Market Size Growth
4.3 APAC Regenerative Medicine Market Size Growth
4.4 Europe Regenerative Medicine Market Size Growth
4.5 Middle East & Africa Regenerative Medicine Market Size Growth

5 Americas
5.1 Americas Regenerative Medicine Market Size by Countries
5.2 Americas Regenerative Medicine Market Size by Type
5.3 Americas Regenerative Medicine Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Regenerative Medicine Market Size by Countries
6.2 APAC Regenerative Medicine Market Size by Type
6.3 APAC Regenerative Medicine Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Regenerative Medicine by Countries
7.2 Europe Regenerative Medicine Market Size by Type
7.3 Europe Regenerative Medicine Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Regenerative Medicine by Countries
8.2 Middle East & Africa Regenerative Medicine Market Size by Type
8.3 Middle East & Africa Regenerative Medicine Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Regenerative Medicine Market Forecast
10.1 Global Regenerative Medicine Market Size Forecast (2019-2024)
10.2 Global Regenerative Medicine Forecast by Regions
10.2.1 Global Regenerative Medicine Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Regenerative Medicine Forecast by Type
10.8 Global Regenerative Medicine Forecast by Application

11 Key Players Analysis
11.1 J & J (DePuy Synthes)
11.1.1 Company Details
11.1.2 Regenerative Medicine Product Offered
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 J & J (DePuy Synthes) News
11.2 Medtronic
11.2.1 Company Details
11.2.2 Regenerative Medicine Product Offered
11.2.3 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Medtronic News
11.3 ZimmerBiomet
11.3.1 Company Details
11.3.2 Regenerative Medicine Product Offered
11.3.3 ZimmerBiomet Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 ZimmerBiomet News
11.4 Stryker
11.4.1 Company Details
11.4.2 Regenerative Medicine Product Offered
11.4.3 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Stryker News
11.5 Allergan(Acelity)
11.5.1 Company Details
11.5.2 Regenerative Medicine Product Offered
11.5.3 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Allergan(Acelity) News
11.6 MiMedx Group
11.6.1 Company Details
11.6.2 Regenerative Medicine Product Offered
11.6.3 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 MiMedx Group News
11.7 Organogenesis
11.7.1 Company Details
11.7.2 Regenerative Medicine Product Offered
11.7.3 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Organogenesis News
11.8 Fujifilm Cellular Dynamics
11.8.1 Company Details
11.8.2 Regenerative Medicine Product Offered
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Fujifilm Cellular Dynamics News
11.9 Osiris Therapeutics
11.9.1 Company Details
11.9.2 Regenerative Medicine Product Offered
11.9.3 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Osiris Therapeutics News
11.10 Vcanbio
11.10.1 Company Details
11.10.2 Regenerative Medicine Product Offered
11.10.3 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Vcanbio News
11.11 CCBC
11.12 Cytori
11.13 Celgene
11.14 Vericel Corporation
11.15 Guanhao Biotech
11.16 Mesoblast
11.17 AMAG Pharmaceuticals (CBR)
11.18 ViaCord
11.19 CordLife
11.20 Integra LifeSciences
11.21 Nuvasive
11.22 Cook Biotech
11.23 Japan Tissue Engineering

12 Research Findings and Conclusion